| Not Yet Recruiting | Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRA Recurrent Adenoid Cystic Carcinoma, Adenoid Cystic Carcinoma Metastatic, Papillary Thyroid Carcinoma | Phase 2 | 2026-05-01 |
| Not Yet Recruiting | Restoring Bile Acid Homeostasis Via Lifestyle Adjustments to Prevent the Development of Liver Cancer Liver Diseases | N/A | 2026-01-01 |
| Recruiting | Histotripsy for Ablation of Liver Tumours in Asia Liver Malignant Tumors | N/A | 2025-11-07 |
| Not Yet Recruiting | Sensory Enrichment Using Aromatherapy for Neurobehavioral and Psychological Symptoms in Early Dementia Mild Cognitive Impairment, Mild Dementia | N/A | 2025-11-01 |
| Active Not Recruiting | Acceptability and Feasibility of PSC Model of Serious Illness Communication Advanced Breast Cancer | N/A | 2025-08-25 |
| Recruiting | Exercise Therapy and Cognitive Behavioural Therapy for Fatigue in Female Cancer Patients in Singapore Fatigue, Breast Cancer Female | N/A | 2025-07-14 |
| Recruiting | Feasibility, Acceptability and Preliminary Efficacy of the New Iteration of the Innovative Smartphone-based Ca Breast Cancer | N/A | 2025-05-23 |
| Recruiting | Intramuscular ACM-CpG Monotherapy in Patients With Advanced/Metastatic Solid Tumors With Prior Response to Imm Advanced Solid Tumor, Metastatic Solid Tumor | Phase 1 | 2025-01-15 |
| Recruiting | Evaluating the Effectiveness of Aromatherapy for Alleviating Distress in Breast Cancer Patients Before Radioth Breast Cancer | N/A | 2024-10-22 |
| Recruiting | Innovating Access to Novel Therapies Through Standardized Prospective Integration of Response Evaluations (IMP Solid Tumor | — | 2024-09-12 |
| Recruiting | Timely Interventions to Enable and Reach Patients With Heart Failure, and Their Caregivers With Palliative Car Heart Failure | N/A | 2024-08-14 |
| Recruiting | Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal Ca Nasopharyngeal Carcinoma | Phase 2 | 2024-07-03 |
| Recruiting | Pembrolizumab and Olaparib Treatment for Relapsed or Refractory Peripheral T-Cell Lymphoma Relapsed Peripheral T-Cell Lymphoma, Refractory Peripheral T-Cell Lymphoma | Phase 2 | 2024-07-01 |
| Recruiting | A Pan-Asian Clinical Database of EGFR Exon 20 Insertion Mutated NSCLC Advanced EGFR Exon 20 Insertion Mutated Non-Small Cell Lung Cancer | — | 2024-03-15 |
| Recruiting | Evaluation and Implementation Preparation of a Proactive Palliative Care Model (ENABLE-SG) Neoplasms | N/A | 2023-12-26 |
| Recruiting | Metronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer P Metastatic Pancreatic Cancer | Phase 2 | 2023-08-30 |
| Active Not Recruiting | A Phase 2 Study of Osimertinib and S-1 in Treatment Resistant EGFR Mutant NSCLC NSCLC | Phase 2 | 2023-08-01 |
| Recruiting | Breast Cancer Exercise Intervention Study Early-stage Breast Cancer, Locally Advanced Breast Cancer | N/A | 2023-07-01 |
| Unknown | Phase II 177Lu-DOTATATE Study in Metastatic NPC With a Safety Run-in Metastatic Nasopharyngeal Cancer | Phase 2 | 2023-05-05 |
| Recruiting | Deep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence to Adjuvant Atezolizumab Plus Bev Hepatocellular Carcinoma | Phase 2 | 2023-02-28 |
| Recruiting | Phase II Lenvatinib and Pembrolizumab in Endocrine Resistant Breast Cancer With Letrozole Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer | Phase 2 | 2023-02-15 |
| Completed | Impacts of Durian Consumption on Human Microbiome and Metabolome in Healthy Staff Volunteers Diet, Food and Nutrition | N/A | 2023-02-01 |
| Recruiting | tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIB Nasopharyngeal Carcinoma | — | 2022-11-17 |
| Recruiting | Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atez Locally Advanced Hepatocellular Carcinoma | Phase 2 | 2022-10-26 |
| Recruiting | SingapOre Lung Cancer Screening Through Integrating CT With Other biomarkErs (SOLSTICE) Lung Cancer | N/A | 2022-07-21 |
| Completed | ENABLE (Educate, Nurture, Advise, Before Life Ends) Intervention for Heart Failure (HF) Patients and Their Car Heart Failure | N/A | 2022-02-14 |
| Completed | PSMA-PET Imaging of Salivary Gland Tumours and Other Rare Cancers Salivary Gland Tumor, Rare Malignant Neoplasm | — | 2022-01-26 |
| Active Not Recruiting | Prospective Cohort Study of Changes in Circulatory MicroRNA of Resected Hepatocellular Carcinoma Hepatocellular Carcinoma | — | 2021-11-10 |
| Active Not Recruiting | Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Advanced Solid Tumours, Non-small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma | Phase 2 | 2021-08-24 |
| Recruiting | PIPAC for Peritoneal Metastases Peritoneal Metastases | Phase 1 | 2021-05-20 |
| Recruiting | Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC Hepatocellular Carcinoma, Hepatocellular Cancer, Colorectal Cancer | Phase 2 | 2021-04-15 |
| Active Not Recruiting | Early Detection of Hepatocellular Carcinoma in a High-risk Prospective Cohort (ELEGANCE) Liver Diseases | — | 2021-04-15 |
| Completed | Impact of a Breast cAncer Survivorship Interprofessional Community Care Model Survivorship, Breast Cancer | N/A | 2021-03-01 |
| Completed | Novel Palliative Care Model for Advanced Cancer Patients: A Randomized Controlled Trial Study Cancer | N/A | 2021-02-08 |
| Recruiting | Telegenetics or In-Person Genetic Counselling Genetic Counselling | — | 2021-02-01 |
| Unknown | Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Pat Breast Cancer | Phase 1 | 2020-12-23 |
| Unknown | Clinical Trial of Chemotherapy, Oregovomab and Nivolumab in Patients With Epithelial Cancer of Ovarian, Tubal Epithelial Ovarian Cancer | Phase 1 / Phase 2 | 2020-10-07 |
| Completed | The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBC Metastatic Triple-Negative Breast Carcinoma | Phase 1 | 2020-10-01 |
| Recruiting | Using QPOP to Predict Treatment for Sarcomas and Melanomas Sarcoma, Melanoma | — | 2020-09-08 |
| Completed | Impact of Measures Taken to Contain COVID-19 on Hospital Surgical Care Services and Clinical Outcomes Surgery | — | 2020-08-01 |
| Completed | Somatostatin Receptor Imaging in NPC, EBV Related Cancers Nasopharyngeal Cancer, Epstein-Barr Virus Related Carcinoma | N/A | 2020-06-29 |
| Completed | Phase 2 Trial in Multiple Brain Metastases Outcomes With HA-SIB-WBRT Brain Metastases | Phase 2 | 2020-06-15 |
| Withdrawn | Nivolumab in Combination With GDP/ L-asparaginase in NK/ T-cell Lymphoma NK/T Cell Lymphoma | Phase 1 | 2019-12-12 |
| Unknown | Longitudinal Immune-phenotyping of HCC Following MK-3475 Hepatocellular Carcinoma | Phase 1 | 2019-12-10 |
| Active Not Recruiting | Phase 2 Study of Dacomitinib in NSCLC NSCLC Stage IIIB, NSCLC Stage IIIC, NSCLC Stage IV | Phase 2 | 2019-09-11 |
| Recruiting | Phase II Study of PRL3-ZUMAB in Advanced Solid Tumors Gastric Cancer, Hepatocellular Carcinoma, Advanced Solid Tumor | Phase 2 | 2019-09-03 |
| Recruiting | Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLC Non-small Cell Lung Cancer, ALK-Positive Lung Cancer | — | 2019-08-23 |
| Completed | Window of Opportunity Study in Colorectal Cancer Colorectal Cancer | Phase 2 | 2019-06-12 |
| Unknown | A Novel Functional Imaging Technique With FLT-PET/MRI For Staging, Response Assessment and Radiation Treatment Image, Body, Cervix Cancer | N/A | 2019-05-14 |
| Recruiting | Molecular Profiling Project Lung Cancer, Non-Small Cell Lung Cancer | — | 2019-01-11 |
| Terminated | Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC Non-small Cell Lung Cancer, Leptomeningeal Disease, Central Nervous System Metastases | Phase 1 | 2018-11-16 |
| Completed | LiverMultiScan Analysis of MRI Scans in HCC Hepatocellular Carcinoma | — | 2018-10-19 |
| Unknown | Study of Trametinib and Ruxolitinib in Colorectal Cancer and Pancreatic Adenocarcinoma Colorectal Cancer, Pancreatic Adenocarcinoma | Phase 1 | 2018-07-31 |
| Unknown | Radical Resection and HIPEC for Recurrent Retroperitoneal Sarcoma Retroperitoneal Sarcoma | N/A | 2018-07-23 |
| Completed | Trial Comparing Active Intervention At Diagnosis With Usual Care to Improve Psycho-social Care in AYAO Carcinoma, Lymphoma, Sarcoma | N/A | 2018-04-16 |
| Completed | Effectiveness of the Supportive and Palliative Care Review Kit (SPARK) for Cancer Patients in the Acute Hospit Health Services Research | N/A | 2017-12-01 |
| Completed | Prophylactic HIPEC for Colorectal Cancers at High Risk of Developing Peritoneal Metastases Colorectal Cancer, Peritoneal Metastases | N/A | 2017-09-28 |
| Completed | Predicting Survival After Surgical Resection for the Entire Spectrum of Anatomically Resectable HCC Hepatocellular Carcinoma Resectable | — | 2017-07-17 |
| Completed | 18F-FMISO PET Guided Dose Escalation in Nasopharyngeal Carcinoma - a Feasibility and Planning Study Nasopharyngeal Carcinoma | N/A | 2017-06-20 |
| Completed | Perioperative Immunonutrition for Patients Undergoing CRS and HIPEC Peritoneal Metastases | N/A | 2017-04-23 |
| Completed | Hepatocellular Carcinoma Registry in Asia: The INSIGHT Registry Hepatocellular Carcinoma | — | 2017-04-17 |
| Terminated | Study of Nivolumab Verses Nivolumab and Ipilimumab Combination in EGFR Mutant Non-small Cell Lung Cancer Non-Small Cell Lung Cancer | Phase 2 | 2017-04-07 |
| Unknown | Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma | Phase 2 | 2017-03-31 |
| Terminated | Phase Ib/IIa Trial to Evaluate Oregovomab and Nivolumab in Epithelial Cancer of Ovarian, Tubal or Peritoneal O Epithelial Ovarian Cancer | Phase 1 / Phase 2 | 2017-02-22 |
| Active Not Recruiting | Study of Y90-Radioembolization With Nivolumab in Asians With Hepatocellular Carcinoma HepatoCellular Carcinoma | Phase 2 | 2016-12-20 |
| Unknown | Regional Cryotherapy in Preventing Paclitaxel Induced Peripheral Neuropathy in Breast Cancer Patients Breast Cancer | Phase 2 | 2016-09-01 |
| Terminated | Phase II Study to Assess the Efficacy of ASLAN001 Plus Capecitabine in CNS Metastases for HER2+ Breast Cancer HER2-positive Breast Cancer | Phase 2 | 2016-08-11 |
| Completed | Enhancing Quality of Life in Patients (EQUIP) Intervention for Patients With Advanced Lung Cancer Advanced Lung Cancer | N/A | 2016-08-01 |
| Terminated | Phase II Study of Ibrutinib in Patients With Relapsed or Refractory Marginal Zone Lymphoma Lymphoma, B-Cell, Marginal Zone | Phase 2 | 2016-07-08 |
| Completed | Phase I Trial of Selinexor (KPT-330) and Ifosfamide, Carboplatin, Etoposide (ICE) in Peripheral T-cell Lymphom Peripheral T-cell Lymphoma | Phase 1 | 2016-07-01 |
| Completed | Prospective Cohort Study on the Clinical Trajectory of Resected Hepatocellular Carcinoma Hepatocellular Carcinoma | — | 2016-05-16 |
| Completed | Use of Regorafenib in Recurrent Epithelial Ovarian Cancer Ovarian Neoplasms | Phase 2 | 2016-02-03 |
| Completed | Pilot Study of the SPaRK (Supportive and Palliative Care Review Kit) Model of Care for Advanced Cancer Patient Cancer | N/A | 2015-11-22 |
| Recruiting | Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients Nasopharyngeal Cancer, Prostate Cancer, Other Cancer | — | 2015-09-30 |
| Completed | Pilot Study of Somatostatin Receptor Imaging in Nasopharyngeal Cancer Nasopharyngeal Carcinoma | — | 2015-08-20 |
| Unknown | Use of Non-invasive 4D Ultrasound Clarity System in Prostate IMRT/RapidArc Therapy Prostate Cancer | — | 2015-04-01 |
| Completed | PRe-Operative Gefitinib in Resectable EGFR Mutation Positive Lung Cancer With Sector Sequencing for Biomarker Non-small Cell Lung Cancer | Phase 2 | 2015-01-27 |
| Unknown | ASLAN001 in Combination With Oxaliplatin and Capecitabine or Oxaliplatin and 5-FU With Leucovorin Solid Tumors | Phase 1 | 2014-08-01 |
| Completed | OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic Adenocarcinoma Pancreatic Cancer | Phase 1 | 2013-09-17 |
| Unknown | Stereotactic Body Radiotherapy for Organ Confined Prostate Cancer Prostate Cancer | Phase 2 | 2013-06-01 |
| Terminated | A Study Into the Effect of Seprafilm in Open Total Thyroidectomy Thyroid Carcinoma | N/A | 2013-05-01 |
| Completed | Comparing Harmonic Ultrasonic Scalpel to Small Jaw Bipolar Device in Thyroid Surgery Thyroid Diseases | N/A | 2012-12-01 |
| Completed | Clinical Study of Metronomic Oral Cyclophosphamide in Patients With Advanced Sarcomas Sarcoma | Phase 2 | 2012-06-01 |
| Completed | A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enr Non-Small Cell Lung Cancer, Solid Tumors | Phase 1 | 2011-10-03 |
| Recruiting | Individualized Molecular Profiling for Allocation to Clinical Trials (IMPACT) Project Solid Tumor | — | 2011-10-01 |
| Terminated | Study of TKI 258 in Combination With Xeloda and Oxaliplatin in Advanced Colorectal and Gastric Cancer Colorectal Cancer, Gastric Cancer | Phase 1 | 2011-09-01 |
| Terminated | Diffuse Optical Tomography (DOT) for Monitoring Response to Neoadjuvant (Preoperative) Chemotherapy in Breast Breast Neoplasms | — | 2011-08-01 |
| Completed | Study of Ofatumomab in Combination With ICE-chemotherapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL Diffuse Large B-cell Lymphoma | Phase 2 | 2011-04-01 |
| Terminated | Bortezomib With Combination of Gemcitabine, Ifosfamide and Oxaliplatin in Untreated NK/T Cell Lymphoma Extranodal NK-T-CELL LYMPHOMA | Phase 2 | 2011-03-01 |
| Completed | Study of Neoadjuvant Docetaxel and Cyclophosphamide in Locally Advanced or Node Positive Primary Breast Cancer Breast Cancer | Phase 2 | 2010-08-11 |
| Completed | A Phase 2 Study of Trastuzumab in Combination With TS-ONE and Cisplatin in Firstline Human Epidermal Growth Fa HER 2 Positive Advanced Gastric Cancer | Phase 2 | 2010-05-01 |
| Unknown | Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors Nasopharyngeal Carcinoma, Lymphomas, Any EBV+ Solid Tumour | Phase 1 | 2010-03-01 |
| Terminated | AZD6244 and Sorafenib in Advanced Hepatocellular Carcinoma Hepatocellular Carcinoma | Phase 1 / Phase 2 | 2009-11-01 |
| Unknown | Clinical Validation of a Microfluidic Device for Isolation and Molecular Characterization of Circulating Tumor Cancer | — | 2009-10-01 |
| Unknown | Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Ad Head and Neck Cancer | Phase 2 / Phase 3 | 2009-09-15 |
| Unknown | Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck Cancer Carcinoma, Squamous Cell of Head and Neck | Phase 3 | 2009-08-13 |
| Unknown | Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers Colorectal Cancer | Phase 3 | 2008-12-01 |
| Unknown | Cyclophosphamide and Docetaxel or Doxorubicin in Treating Women With Newly Diagnosed Breast Cancer That Can Be Breast Cancer | Phase 2 | 2008-10-01 |
| Unknown | Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic Head and Neck Cancer | Phase 2 | 2008-07-01 |
| Completed | Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lun Non-Small Cell Lung Cancer | Phase 1 | 2008-06-01 |
| Unknown | Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postm Breast Cancer | Phase 2 | 2008-05-01 |
| Completed | Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancer Head and Neck Cancer | Phase 2 | 2008-04-28 |
| Completed | Irinotecan in Treating Asian Patients With Solid Tumors Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 2008-04-03 |
| Completed | Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung Cancer Non-Small Cell Lung Cancer | Phase 1 | 2008-04-01 |
| Terminated | Paclitaxel, Doxorubicin, and Cyclophosphamide With Or Without Carboplatin in Treating Women With Locally Advan Breast Cancer | Phase 2 | 2008-01-01 |
| Unknown | Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer Head and Neck Cancer | Phase 2 | 2007-11-01 |
| Terminated | Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer Dermatologic Complications, Palmar-plantar Erythrodysesthesia, Unspecified Adult Solid Tumor, Protocol Specific | Phase 3 | 2007-06-01 |
| Unknown | Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cann Liver Cancer | Phase 2 | 2007-03-01 |
| Completed | Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery Liver Cancer | Phase 1 | 2006-12-01 |
| Unknown | Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously U Head and Neck Cancer | Phase 3 | 1998-09-01 |
| Completed | Surgery and Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Stage Head and Neck Cancer | Phase 3 | 1997-01-01 |